Outlook Therapeutics, Inc.Pembelian
OTLK Bullish
Price is at the POC line (1yr) with increasing avg. daily volume since mid April.
OBV is displaying bullish divergence since June as it has been increasing while the price has been decreasing.
RSI is about to cross over its 13 ema.
Targeting: 2.25, 2.66
Stop 2x ATR at $1.56
OBV is displaying bullish divergence since June as it has been increasing while the price has been decreasing.
RSI is about to cross over its 13 ema.
Targeting: 2.25, 2.66
Stop 2x ATR at $1.56
Pernyataan Penyangkalan
Informasi dan publikasi tidak dimaksudkan untuk menjadi, dan bukan merupakan saran keuangan, investasi, perdagangan, atau rekomendasi lainnya yang diberikan atau didukung oleh TradingView. Baca selengkapnya di Persyaratan Penggunaan.